benzoxazoles has been researched along with cardiovascular agents in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
CAIN, CK; PLAMPIN, JN | 1 |
Ao, Z; Bradley, BT; Daniels, E; Douglas, SA; Gatto, GJ; Goodman, KB; Goserud, MT; Harpel, MR; Johns, DG; Kearse, MG; Morales, CR; Zhou, M | 1 |
Hayward, LF; Hernandez, ME; Martin, EJ | 1 |
Autore, C; Canepa, M; Cappelli, F; Milandri, A; Mussinelli, R; Musumeci, B; Perfetto, F; Perlini, S; Rapezzi, C; Tini, G | 1 |
Butler, J; Khan, MS; Vaduganathan, M | 1 |
Almeida, AR; Azevedo, O; Bento, D; Correia, E; Cruz, I; Lopes, LR; Lourenço, C; Marques, N | 1 |
Benbrahim, M; Hughes, D; Norman, K; Sanchorawala, V; Siddiqi, OK | 1 |
2 review(s) available for benzoxazoles and cardiovascular agents
Article | Year |
---|---|
Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations.
Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Genetic Therapy; Humans | 2020 |
A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis.
Topics: Amyloid Neuropathies, Familial; Animals; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Diflunisal; Genetic Predisposition to Disease; Humans; Mutation; Oligonucleotides; Phenotype; Prealbumin; RNA, Small Interfering; Treatment Outcome | 2021 |
5 other study(ies) available for benzoxazoles and cardiovascular agents
Article | Year |
---|---|
SYNTHESIS OF METABOLIC PRODUCTS OF BENZOXAZOLES.
Topics: Benzoxazoles; Cardiovascular Agents; Chemistry, Pharmaceutical; Metabolism; Mice; Muscle Relaxants, Central; Oxazoles; Pharmacology; Research; Zoxazolamine | 1963 |
NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation.
Topics: Base Sequence; Benzoxazoles; Cardiovascular Agents; Cells, Cultured; Enzyme Inhibitors; Humans; Membrane Glycoproteins; Molecular Sequence Data; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Perhexiline; Protein Kinase C; Protein Kinase C beta; Reactive Oxygen Species; Suramin; Triazoles | 2013 |
Blockade of orexin receptors attenuates the cardiovascular response to air-jet stress in spontaneously hypertensive rats.
Topics: Acetamides; Air; Animals; Benzoxazoles; Blood Pressure; Brain; Brain-Derived Neurotrophic Factor; Cardiovascular Agents; Dose-Response Relationship, Drug; Heart Rate; Isoquinolines; Male; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Physical Stimulation; Random Allocation; Rats, Inbred SHR; Rats, Wistar; RNA, Messenger; Species Specificity; Stress, Psychological; Urea | 2016 |
Real-world versus trial patients with transthyretin amyloid cardiomyopathy.
Topics: Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Angiotensin-Converting Enzyme Inhibitors; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Clinical Trials as Topic; Diuretics; Female; Humans; Male; Rare Diseases | 2019 |
Orphan Drug Development in Cardiovascular Medicine.
Topics: Benzoxazoles; Cardiovascular Agents; Cardiovascular Diseases; Cost-Benefit Analysis; Drug Approval; Drug Costs; Drug Development; Humans; Orphan Drug Production; Treatment Outcome | 2020 |